Kovitz Investment Group Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.03M Buy
66,758
+24,856
+59% +$2.87M 0.19% 108
2025
Q4
$4.41M Sell
41,902
-325,351
-89% -$30.5M 0.1% 151
2025
Q3
$30.9M Sell
367,253
-936,627
-72% -$77.1M 0.12% 161
2025
Q2
$103M Sell
1,303,880
-204,026
-14% -$16.2M 0.44% 61
2025
Q1
$135M Buy
1,507,906
+167,772
+13% +$15.7M 0.68% 36
2024
Q4
$133M Buy
1,340,134
+1,119,080
+506% +$115M 0.65% 39
2024
Q3
$21M Buy
221,054
+99,236
+81% +$11.8M 0.15% 130
2024
Q2
$15.1M Sell
121,818
-380
-0.3% -$48.9K 0.13% 121
2024
Q1
$16.1M Buy
122,198
+36,127
+42% +$4.45M 0.2% 72
2023
Q4
$9.38M Sell
86,071
-107
-0.1% -$11.1K 0.16% 73
2023
Q3
$8.87M Sell
86,178
-3,748
-4% -$404K 0.16% 78
2023
Q2
$10.4M Sell
89,926
-5,663
-6% -$643K 0.15% 67
2023
Q1
$10.2M Sell
95,589
-3,144
-3% -$339K 0.18% 71
2022
Q4
$11M Sell
98,733
-877
-0.9% -$89.6K 0.22% 68
2022
Q3
$8.58M Buy
99,610
+753
+0.8% +$67.2K 0.2% 78
2022
Q2
$9.01M Sell
98,857
-5,925
-6% -$525K 0.2% 80
2022
Q1
$8.6M Buy
104,782
+11,622
+12% +$916K 0.16% 91
2021
Q4
$7.62M Sell
93,160
-69,336
-43% -$5.52M 0.18% 84
2021
Q3
$12.2M Sell
162,496
-796
-0.5% -$60.5K 0.24% 57
2021
Q2
$12.7M Buy
163,292
+39,507
+32% +$2.94M 0.25% 55
2021
Q1
$9.11M Buy
123,785
+26,154
+27% +$1.93M 0.21% 78
2020
Q4
$7.62M Sell
97,631
-2,563
-3% -$196K 0.19% 82
2020
Q3
$7.93M Buy
100,194
+2,482
+3% +$194K 0.22% 73
2020
Q2
$7.21M Buy
97,712
+24,856
+34% +$1.87M 0.22% 71
2020
Q1
$5.35M Buy
72,856
+3,288
+5% +$258K 0.19% 87
2019
Q4
$6.04M Sell
69,568
-343
-0.5% -$28.2K 0.18% 90
2019
Q3
$989K Buy
69,911
+2,525
+4% +$202K 0.03% 266
2019
Q2
$5.39M Buy
67,386
+10,313
+18% +$790K 0.17% 94
2019
Q1
$4.53M Buy
57,073
+1,019
+2% +$76.2K 0.14% 107
2018
Q4
$4.09M Buy
56,054
+51,225
+1,061% +$3.62M 0.16% 98
2018
Q3
$327K Buy
4,829
+53
+1% +$3.38K 0.01% 130
2018
Q2
$277K Sell
4,776
-676
-12% -$38.1K 0.01% 134
2018
Q1
$283K Sell
5,452
-515
-9% -$27.8K 0.01% 129
2017
Q4
$320 Buy
5,967
+15
+0.3% +$832 0.01% 136
2017
Q3
$364K Sell
5,952
-104
-2% -$6.3K 0.02% 128
2017
Q2
$370K Sell
6,056
-413
-6% -$25.1K 0.02% 129
2017
Q1
$392K Buy
6,469
+110
+2% +$6.67K 0.02% 108
2016
Q4
$357K Buy
6,359
+314
+5% +$18.4K 0.02% 99
2016
Q3
$360K Hold
6,045
0.02% 109
2016
Q2
$332K Buy
6,045
+71
+1% +$3.78K 0.02% 111
2016
Q1
$302K Buy
+5,974
New +$293K 0.02% 117

Other funds holding MRK

Kovitz Investment Group Partners's MRK Position: Q1 2026 in Review

Kovitz Investment Group Partners increased its Merck (MRK) stake by 59% in Q1 2026, buying an estimated $2.87M and bringing the position to 66,758 shares worth $8.03M. The position accounts for 0.19% of the portfolio, ranked #108.

Kovitz Investment Group Partners first reported a position in MRK in Q1 2016 and has held it in 41 quarters since. The position peaked at $135M in Q1 2025. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Kovitz Investment Group Partners held 66,758 shares of Merck worth $8.03M as of Q1 2026.
  • Kovitz Investment Group Partners bought 24,856 Merck shares in Q1 2026, an estimated $2.87M.
  • Merck made up 0.19% of Kovitz Investment Group Partners's portfolio in Q1 2026, its #108 holding.
  • Kovitz Investment Group Partners first reported a position in Merck in Q1 2016 and has held it in 41 quarters since.
  • Kovitz Investment Group Partners's Merck position peaked at $135M in Q1 2025.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Kovitz Investment Group Partners's 13F filing for Q1 2026, filed 13 May 2026.